Inflammatory cytokines in juvenile idiopathic arthritis: Effects on physical growth and the insulin-like-growth factor axis

Growth Hormone and IGF Research

Volumn 18, Issue 5, 2008, Pages 369-378

  Wong, S C ^a   MacRae, V E ^a,b   Gracie, J A ^c   McInnes, I B ^c   Galea, P ^c   Gardner Medwin, J ^c   Ahmed, S F ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cytokines; Growth; Inflammation; Insulin like growth factor 1; Juvenile idiopathic arthritis

Indexed keywords

ACID LABILE SUBUNIT; BIOLOGICAL FACTOR; CYTOKINE; GROWTH HORMONE; INTERLEUKIN 15; INTERLEUKIN 5; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3;

ADOLESCENT; ARTHROCENTESIS; ARTICLE; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GROWTH; GROWTH RETARDATION; HORMONE RELEASE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBERTY; SHORT STATURE;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; GROWTH DISORDERS; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-5; INTERLEUKIN-6; MALE; PROSPECTIVE STUDIES; PUBERTY;

EID: 46749147206     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.01.006     Document Type: Article

References (30)

1. Mangge H., and Schuenstein K. Cytokines in juvenile rheumatoid arthritis (JRA). Cytokine 10 (1998) 471-480
2. Zak M., Muller J., and Karup Pedersen K. Final height, armspan, subischial leg length and body proportions in juvenile chronic arthritis. Horm. Res. 52 (1999) 80-85
3. Wang S.J., Yang Y.H., Lin Y.T., Yang C.M., and Chiang B.L. Attained adult height in juvenile rheumatoid arthritis with or without corticosteroid treatment. Clin. Rheumatol. 21 (2002) 363-368
4. Simon D., Fernando C., Czernichow P., and Prieur A.M. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with long term glucocorticoids. J. Rheumatol. 29 (2002) 1296-1300
5. Davies U.M., Jones J., Reeve J., Camacho-Hubner C., Charlett A., Ansell B.M., Preece M.A., and Woo P.M.M. Juvenile rheumatoid arthritis: effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3. Arthritis Rheum. 40 (1997) 332-340
6. Allen R.C., Jimenez M., and Cowell C.T. Insulin-like growth factor and growth hormone secretion in juvenile chronic arthritis. Ann. Rheum. Dis. 50 (1991) 602-606
7. MacRae V.E., Farquharson C., and Ahmed S.F. The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J. Endocrinol. 189 (2006) 319-328
8. Martensson K., Chrysis D., and Savendahl L. Interleukin-1 beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J. Bone Miner. Res. 19 (2004) 1805-1812
9. De Benedetti F., Meazza C., Oliveri M., Pignatti P., Vivarelli M., Alonzi T., Fattori E., Garrone S., Barreca A., and Martini A. Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology 142 (2001) 4818-4826
10. Street M.E., de Angelis G.L., Camacho-Hubner C., Giovannelli G., Ziveri M.A., Bacchini P.L., Bernasconi S., Sansebastiano G., and Savage M.O. Relationship between serum IGF-1, IGFBP2, interleukin-1beta and interleukin-6 in inflammatory bowel disease. Horm. Res. 61 (2004) 159-164
11. de Jager W., Hoppenreijs E.P., Wulffraat N.M., Wedderburn L.R., Kuis W., and Prakken B.J. Blood and synovial fluid cytokine signature in patients with juvenile idiopathic arthritis: a cross sectional study. Ann. Rhem. Dis. 66 (2007) 589-598
12. Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., He X., Maldonado-Cocco J., Orozco-Alcala J., Prieur A.M., Suarez-Almazor M.E., Woo P., and International League of Association for Rheumatology. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J. Rheumatol. 31 (2004) 390-392
13. Cole T.J., Freeman J.V., and Preece M.A. Body mass index reference curves for the UK, 1990. Arch. Dis. Child 73 (1995) 25-29
14. Freeman J.V., Cole T.J., Chinn S., Jones P.R., White E.M., and Preece M.A. Cross sectional stature and weight reference curves for the UK, 1990. Arch. Dis. Child 73 (1995) 17-24
15. Brabant G., von zur Muhlen A., Wuster C., Ranke M.B., Kratzech J., Kiess W., Ketelslegers J.M., Wilhelmsen L., Hulthen L., Saller B., Mattson A., Wilde J., Schemer R., and Kann P. Serum insulin-like growth factor 1 reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm. Res. 60 (2003) 53-60
16. Juul A., Moller S., Mosfeldt-Laursen E., Rasmussen M.H., Scheike T., Pedersen S.A., Kastrup K.W., Yu H., Mistry J., Rasmussen S., Muller J., Henriksen J., and Skakkebaek N.E. The acid-labile subunit of the human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 4408-4415
17. Juul A., Dalgaard P., Blum W.F., Bang P., Hall K., Michaelsen K.F., Muller J., and Skakkebaek N.E. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children and adolescents: the relation to IGF1, IGFII, IGFBP1, IGFBP2, age, sex, body mass index and pubertal maturation. J. Clin. Endocrinol. Metab. 80 (1995) 2534-2542
18. Lofqvust C., Andersson E., Gelander L., Rosberg S., Hultehn L., Blum W.F., and Wikland K.A. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor I to IGFBP3 throughout childhood and adolescence. J. Clin. Endocrinol. Metab. 90 (2005) 1420-1427
19. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., and Woo P. The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102 (1998) 1369-1376
20. Schikler K.N. Growth hormone therapy in juvenile arthritis: importance of classification. J. Peditar. 145 (2004) 423-424
21. Bareca A., Ketelslegers J.M., Arvigo M., Minuto F., and Thisen J.P. Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1β in vitro. Growth Horm. IGF Res. 8 (1998) 217-223
22. Tynjala P., Lahdenne P., Vahasalo P., Kautiainen H., and Honkanen V. Impact of anti-TNF therapy on growth in severe juvenile idiopathic arthritis. Ann. Rheum. Dis. 65 (2006) 1044-1049
23. Bechtold S., Ripperger P., Hafner R., Said E., and Scharz H.P. Growth hormone improves height in patients with juvenile idiopathic arthritis: 4 year data of a controlled study. J. Pediatr. 143 (2003) 512-519
24. Saha M.T., Haapasaari J., Hannula S., Sarna S., and Lenko H.L. Growth hormone is effective in the treatment of severe growth retardation in children with juvenile chronic arthritis. Double blind placebo-controlled follow up study. J. Rheumatol. 31 (2004) 1413-1417
25. Bucuvalas J.C., Chernausek S.D., Alfaro M.P., Krug S.K., Ritschel W., and Wilmot R.W. Effect of insulin like growth factor-1 treatment in children with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 33 (2001) 576-581
26. Gouwy M., Struyf S., Proost P., and Van Damme J. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev. 16 (2005) 561-580
27. Smolewska E., Brozik H., Smolewski P., Biernacka-Zielinska M., Darzynkiewicz Z., and Stanczy J. Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis. Ann. Rheum. Dis. 62 (2003) 761-763
28. Bierbaum S., Sengler C., Gerhold K., Berner R., and Heinzmann A. Polymorphism within interleukin 15 are associated with juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 24 (2006) 219
29. McInnes I.B., and Gracie J.A. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr. Opin. Pharmacol. 4 (2004) 392-397
30. Baslund B., Tvede N., Danneskiold-Samsoe B., Larsson P., Panayi G., Petersen J., Petersen L.J., Beurskens F.J.M., Schuurman J., van de Winkel J.G.J., Parren P.W.H.I., Gracie J.A., Jongbloed S., Liew F.Y., and McInnes I.B. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof of concept study. Arthritis Rheum. 59 (2005) 2686-2692